Location: Home
  • search
  • go
  • Relate News
  • 9/18/2018Fosun Pharma Sees 'Huge' Opportunities in India, Southeast Asia, Afric...
  • 8/28/2018I-Mab Approved to Initiate Clinical Study of Genexine’s Diabetes Drug
  • 8/16/2018Indian Drugmakers Hit by Rising Prices of Chinese Intermediates
  • 8/14/2018India's Pharmexcil to sign MoU with China Trade Body for Expedite Drug...
  • 7/24/2018The Diabetes Market in China
  • 7/12/2018Merck and Xian Janssen to Co-launch Type 2 Diabetes Drug in China
  • 7/10/2018China Agrees to Slash Import Duties on Indian Medicines
  • 7/6/2018Chinese Film Defending Smuggled Indian Anticancers Triggers Intensive ...
  • 6/25/2018Global Times: India Must Boost Innovation to Benefit from China's Open...
  • 6/19/2018India Releases Study for Enhancing Access to the Chinese Pharma Market
  • 6/13/2018China to Conduct Training Programs for Indian Pharma Cos
  • 6/8/2018Novo Nordisk Still Has Ample Room for Growth in China
  • 6/7/2018CNDA Suspends Import of Ambroxol Hydrochloride from India's Shilpa Med...
  • 5/15/2018Indian Pharma Not Impressed with Latest Chinese Move to Reduce Cancer ...
  • 4/26/2018Adocia and Tonghua Dongbao Announce a Strategic Alliance for Insulin P...
  • 4/24/2018NCCD, Lilly China Enter Collaboration for CVD Research
  • 3/28/2018China, India in Talks over Pharma and Agri Trade Issues in the Face of...
  • 3/13/2018Novo Nordisk Launches New Insulin Degludec Tresiba in China
  • 2/13/2018India Pharma Companies See Growing Opportunities in China following Re...
  • 1/19/2018India to Blacklist Eight Chinese Pharma Companies for Quality Issues
  • 1/15/2018Type 1 Diabetes on the Rise in China, Most New Cases in Adults
  • 12/21/2017vTv Therapeutics Licenses GLP-1r Agonist Diabetes Program to Huadong P...
  • 12/21/2017Fast Rising Price of Chinese APIs Puts Pressure on Bottom Lines of Ind...
  • 11/8/2017CFDA Suspends Import of Rabeprazole API from India for Chinese GMP Iss...
  • 10/30/2017Sumitomo Dainippon and Poxel Enter Partnership for Novel Diabetes Drug...
  • 10/10/2017Indian and Chinese Drugmakers Dominate Asia Power Ranking
  • 9/27/2017CFDA Approves Boehringer/Lilly's Jardiance (Empagliflozin) for Type 2 ...
  • 9/27/2017Novo Nordisk Diabetes Drug Approved in China
  • 9/22/2017Novo Nordisk Eyes Growth GLP-1 Diabetes Drugs in Untapped China
  • 9/14/2017China Sets Up The Changing Diabetes Foundation with Help of Novo Nordi...
  • Page:8/18 Total number of articles:524: [First][<<] [6] [7] [8] [9] [10] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group